Skip to content

MolecuLightDX System 2094

by MolecuLight Inc

MolecuLightDX System 2094 is a Class II device made by MolecuLight Inc, cleared under FDA 510(k) K211901 on 21 Jul 2021 and listed in FDA GUDID since 4 Jan 2022 (UDI-DI 00628110259387), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K211901

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00628110259387 UDI-DI Date4 Jan 2022ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k) from GUDID NumberK211901 Date21 Jul 2021IssuedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K211901 decided 21 Jul 2021 Active
  • FDA GUDID UDI-DI 00628110259387 listed 4 Jan 2022 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K211901
  2. Listed FDA GUDID 00628110259387

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
MolecuLightDX System
Generic name
Fluorescence wound imaging unit
Model / reference
2094
Primary DI / UDI-DI
00628110259387
510(k) Number
FDA product code
QJF
GMDN term
Fluorescence wound imaging unit
Device class
Class II
Regulation number
878.4550
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code QJF (Autofluorescence Imaging Adjunct Tool For Wounds).

Other devices from MolecuLight Inc

See all devices from MolecuLight Inc →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)